CONNECT WITH US
HealthTech

HealthTech

Clinical Validation Audits Are Putting Hospital Reimbursement at Risk

HIT Consultant logo

Published on

Add as a preferred source on Google
Clinical Validation Audits Are Putting Hospital Reimbursement at Risk

When was the last time your team won an appeal on a clinical validation downgrade? If you have to stop and think about it, you are not alone.

Payer behavior has made this harder than it used to be. Clinical validation audits are driving a marked rise in Diagnosis-Related Group (DRG) downgrades, forcing hospitals to defend diagnoses that, for years, were accepted on the strength of a physician’s documentation alone. As audits grow more frequent and the criteria keep shifting, traditional coding and documentation practices no longer secure full reimbursement.

The exposure is real. In 2025, hospitals spent nearly $18 billion overturning claims denials, according to the American Hospital Association. Against margins this thin, even a modest rate of downgrades adds up quickly.

But the teams that protect the most revenue don’t just win more appeals. They reduce their exposure earlier, before claims are submitted and contracts are signed.

Traditional DRG validation audits confirm that diagnoses and procedures are coded and sequenced correctly, in line with the official ICD-10-CM guidelines. In that review, a provider’s statement that a condition exists is generally enough for code assignment, because the focus is on applying coding rules rather than second-guessing the clinical reasoning behind the diagnosis.

Clinical validation audits work differently. Since their introduction in the 2011 Recovery Audit Contractor (RAC) Statement of Work , payers have applied a separate standard, testing whether objective evidence in the medical record, such as laboratory results, imaging, clinical signs, and treatment response, supports the diagnosis itself.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.